LEADING CANCER RESEARCHER TO OFFER POLICIES TO COMBAT DISEASE, SHAPE HEALTH CARE DEBATE
WASHINGTON, Feb. 11 /PRNewswire-USNewswire/ -- Dr. John Mendelsohn, president of The
Mendelsohn will offer a 10-point plan to shape congressional debate about the future of scientific research and cancer prevention and the role it plays in health care reform.
He will address the need to train more health care professionals and scientists to replace retiring baby boomers and to reduce costs while
improving access to high-quality care.
Cancer cost the nation more than $200 billion in direct and indirect costs in 2007, when more than 10.8 million Americans were living with the disease. The World Health Organization reports that cancer causes one in eight deaths worldwide -- more than malaria, tuberculosis and AIDS combined.
Mendelsohn is an acclaimed clinical scientist whose research demonstrated how growth factors regulate the proliferation of cancer cells through a process that activates receptors on cell surfaces. His work eventually led to the drug cetuximab (Erbitux(TM)), approved by the FDA in 2004 for treating advanced colorectal cancer and in 2006 for head and neck cancer.
M. D. Anderson is a world leader in cancer patient care and research, treating more than 89,000 people in 2008. The center, which has an annual budget of nearly $2.8 billion and employs more than 18,000, has more received more research funding from the National Cancer Institute than any other U.S. institution. Located in Houston, the center educates more than 5,000 trainees annually.
|SOURCE National Press Club|
Copyright©2009 PR Newswire.
All rights reserved